
Greater Cannabis Co., Inc. is a US-based investment holding firm, focusing on cannabis industry opportunities through various ventures.
Greater Cannabis Co., Inc., founded as an investment holding firm, focuses on the cannabis industry through diverse ventures such as online retail, direct equity investments, joint ventures, and licensing agreements. The company is dedicated to advancing novel therapies for neuropsychiatric disorders, including autism spectrum disorders (ASD). Their core mission is to leverage cannabinoid therapeutics to develop transformative treatments, addressing significant unmet medical needs in the United States and beyond.
Notable affiliated people and investors include key figures in the biotech and cannabis industries, though specific names are not disclosed. A significant achievement is the approval by the Israeli Ministry of Health for a clinical trial to test their neuroprotective cannabinoid therapeutic. This milestone underscores their impact on advancing medical cannabis research and potential treatments for neuropsychiatric conditions, positioning Greater Cannabis as a pioneering entity in the therapeutic cannabis market.

AmeriCann
americann.co

Dogecoin Cash
cbds.com

Cannformatics
cannformatics.com
Cannabis Growth Opportunity

Natural State Medical Group

Grassp Health

Green Thumb Industries
gtigrows.com

Medical Marijuana

Tilray
tilraymedical.ca
THC Farmaceuticals
toke.city

CuraleafHoldnc.
curaleaf.com

Green Star Growing

Clear Cannabis

Canopy Growth
canopygrowth.com

Cannabis Strategic Ventures
Companies similar to Greater Cannabis include AmeriCann, Dogecoin Cash, Cannformatics and Cannabis Growth Opportunity.
Greater Cannabis was founded in 2014.
Greater Cannabis' headquarters is located in Baltimore, MD, US.
Greater Cannabis has 5 employees as of Feb 5, 2024.